Dr Aris Hadjinicolaou est un neurologue et épileptologue pédiatrique, diplômé en médecine de l’Université de Montréal. Il a complété sa résidence en pédiatrie à l’Université McGill, un fellowship en neurologie pédiatrique à l’Université de Toronto au SickKids’s Hospital, puis un fellowship en épilepsie et neurophysiologie clinique au Boston Children’s Hospital de l’Université Harvard.

Depuis 2022, il est co-responsable (avec le Dr Alexander Weil) du programme de chirurgie de l’épilepsie, co-responsable (avec les Drs Inge Meijer et Alexander Weil) du premier programme de neuromodulation compréhensive du Québec, ainsi que directeur de programme de la formation complémentaire (fellowship) en épilepsie pédiatrique de l’Université de Montréal.

Dans le laboratoire qu’il co-dirige avec Dr Alexander Weil, sa recherche traite de l'épilepsie pédiatrique, de l'identification de facteurs prédictifs des effets post-chirurgie de l'épilepsie, de la découverte de nouveaux traitements et de l'application de nouvelles technologies en neurochirurgie de l’épilepsie, afin de rendre la chirurgie plus sécuritaire, efficace et d’améliorer la survie des patients.

• Goel K, Niazi F, Chen JS, Hadjinicolaou A, Keezer M, Gallagher A, Fallah A, Weil AG. Outcomes following surgical interventions for hypothalamic hamartomas: protocol for a systematic review and individual patient data meta-analysis. BMJ Open. 2024 Feb 12;14(2):e080870. doi: 10.1136/bmjopen-2023-080870
• Hadjinicolaou A, Briscoe Abath C, Singh A, Donatelli S, Salussolia CL, Li Cohen A, He J, Gupta N, Merchant S, Zhang B, Olson H, Yuskaitis CJ, Libenson MH, Harini C. Timing the clinical onset of epileptic spasms in infantile epileptic spasms syndrome: A tertiary health center's experience. Epilepsia, first published: 05 February 2024 https://doi.org/10.1111/epi.17900.
• Yoganathan S, Whitney R, Thomas M, Danda S, Chettali AM, Prasad AN, Farhan SMK, AlSowat D, Abukhaled M, Aldhalaan H, Gowda VK, Kinhal UV, Bylappa AY, Konanki R, Lingappa L, Parchuri BM, Appendino JP, Scantlebury MH, Cunningham J, Hadjinicolaou A, Moufawad El Achkar C, Kamate M, Menon RN, Jose M, Riordan G, Kannan L, Jain V, Manokaran RK, Chau V, Donner EJ, Costain G, Minassian BA, Jain P. KCTD7-related progressive myoclonic epilepsy: Report of 42 cases and review of literature. Epilepsia. First published: 17 January 2024 https://doi.org/10.1111/epi.17880
• Ramani PK, Briscoe Abath C, Donatelli S, Hadjinicolaou A, Vega Toro S, Acevedo K, Rosso Astorga K, Parbhoo K, Singh A, Catenaccio E, Jain P, Kumar Sahu J, Debopam S, Harini C. Initial combination versus early sequential standard therapies for Infantile Epileptic Spasms Syndrome—Feedback from stakeholders. Epilepsia Open. First published: 13 January 2024 https://doi.org/10.1002/epi4.12895.
• Briscoe Abath C, Gupta N, Hadjinicolaou A, Donatelli S, Singh A, Merchant S, Ryan ME, Soby M, Ryan C, Nelson AK, Maldonado Pacheco JE, Zhang B, Williams DN, Yuskaitis CJ, Harini C. Delays to Care in Infantile Epileptic Spasms Syndrome: Racial and Ethnic Inequities. Epilepsia. 12 novembre 2023. https://doi.org/10.1111/epi.17827
• Singh A, Hadjinicolaou A, Peters JM, Salussolia CL. Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions. Neuropsychiatr Dis Treat. 2023;19:733-748. doi.org/10.2147/NDT.S347327
• Goel K, Pek V, Shlobin NA, Chen J-S, Wang A, Ibrahim GM; Hadjinicolaou A, Roessler K, Dudley RW, Nguyen DK, El-Tahry R, Fallah A, Weil AG. Clinical Utility of Intraoperative Electrocorticography for Epilepsy Surgery: A Systematic Review and Meta-Analysis. Epilepsia. 2023 Feb;64(2):253-265. doi: 10.1111/epi.17472. Epub 2022 Dec 12. PMID: 36404579.
• Sheikh IS, Katyal R, Hadjinicolaou A, Nascimento FA, Beniczky S. Roadmap to EEGs: video-based e-learning modules addressing clinical EEG reading. Epileptic Disord. 2022 Dec 1;24(6):1-7. doi: 10.1684/epd.2022.1495. PMID: 36266988.
• Sheikh IS, Katyal R, Hadjinicolaou A, Beniczky S, Nascimento FA. Introducing the Epileptic Disorders Internship Program. Epileptic Disord. 2022 Dec 1;24(6):1-2. English. doi: 10.1684/epd.2022.1485. PMID: 36125363.
• Hadjinicolaou A, Ngo KJ, Conway DY, Baker SK, Provias J, Brady L, Scherer S, Bennett C, La Spada A, Fogel BL, Yoon G. De Novo Pathogenic Variant in SETX causes a rapidly progressive neurodegenerative disorder of early childhood-onset with severe demyelinating polyneuropathy. ACCEPTÉ par Acta Neuropathologica Communications, octobre 2021.
• Hadjinicolaou A, Duan L, Kraus R, Lirette MP, Beck CE, Gardam M. "Call Me by My Name": Improving Communication with Family Members at the Bedside via the Caregiver Identification Badge. Healthc Q. 2021 Jan;23(4):60-64. doi: 10.12927/hcq.2020.26391. PMID: 33475494.
• Hadjinicolaou A, Jain P, Arya R, Roth C, Whitney R, Yau I, Greiner HM, Mangano FT, Rutka JT, Go C. Generator replacement with cardiac-based VNS device in children with T drug-resistant epilepsy: An observational study. [published online ahead of print, 2020 Jul 16]. Epilepsy Res. 2020;167:106431. doi:10.1016/j.eplepsyres.2020.106431
• Hadjinicolaou A, Ng P, Zhang X, Koclas L, Lamarre C, Malouin F, Pigeon N, Richards CL, Shevell M, Oskoui M. Is Cerebral Palsy Spectrum Disorder Changing in High Resource Settings? Data from the Quebec Cerebral Palsy Registry. J Child Neurol. 2019 May 10:883073819845272. doi: 10.1177/0883073819845272.